CareDx (CDNA) Stock Forecast, Price Target & Predictions
CDNA Stock Forecast
CareDx stock forecast is as follows: an average price target of $31.00 (represents a 2.92% upside from CDNA’s last price of $30.12) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.
CDNA Price Target
The average price target for CareDx (CDNA) is $31.00 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $40.00 to $15.00. This represents a potential 2.92% upside from CDNA's last price of $30.12.
CDNA Analyst Ratings
According to 6 Wall Street analysts, CareDx's rating consensus is 'Buy'. The analyst rating breakdown for CDNA stock is 0 'Strong Buy' (0.00%), 4 'Buy' (66.67%), 1 'Hold' (16.67%), 1 'Sell' (16.67%), and 0 'Strong Sell' (0.00%).
CareDx Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 19, 2024 | Mark Massaro | BTIG | $40.00 | $33.00 | 21.21% | 32.80% |
| Aug 16, 2024 | Bill Bonello | Craig-Hallum | $40.00 | $32.98 | 21.29% | 32.80% |
| Aug 01, 2024 | Bill Bonello | Craig-Hallum | $32.00 | $19.99 | 60.08% | 6.24% |
| Apr 17, 2024 | Mason Carrico | Stephens | $15.00 | $8.29 | 80.94% | -50.20% |
| Feb 06, 2023 | - | Goldman Sachs | $29.00 | $16.26 | 78.35% | -3.72% |
| Apr 25, 2022 | - | Stephens | $50.00 | $31.72 | 57.63% | 66.00% |
The latest CareDx stock forecast, released on Aug 19, 2024 by Mark Massaro from BTIG, set a price target of $40.00, which represents a 21.21% increase from the stock price at the time of the forecast ($33.00), and a 32.80% increase from CDNA last price ($30.12).
CareDx Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 3 | 4 |
| Avg Price Target | $40.00 | $37.33 | $31.75 |
| Last Closing Price | $30.12 | $30.12 | $30.12 |
| Upside/Downside | 32.80% | 23.94% | 5.41% |
In the current month, the average price target of CareDx stock is $40.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 32.80% increase as opposed to CareDx's last price of $30.12. This month's average price target is up 7.15% compared to last quarter, and up 25.98% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 27, 2024 | Wells Fargo | - | Underweight | Initialise |
| Aug 19, 2024 | BTIG | - | Buy | Upgrade |
| Aug 01, 2024 | Craig-Hallum | Buy | Buy | Hold |
| Jul 17, 2024 | Stephens | Buy | Buy | Hold |
| May 17, 2024 | Craig-Hallum | Buy | Buy | Hold |
| May 13, 2024 | Stephens | Buy | Buy | Hold |
| May 13, 2024 | Raymond James | Outperform | Market Perform | Downgrade |
| May 01, 2024 | Craig-Hallum | - | Buy | Upgrade |
| Apr 17, 2024 | Stephens | Overweight | Overweight | Hold |
| Nov 09, 2023 | Stephens | - | Overweight | Upgrade |
CareDx's last stock rating was published by Wells Fargo on Aug 27, 2024. The company Initialise its CDNA rating from "null" to "Underweight".
CareDx Financial Forecast
CareDx Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $67.19M | $70.30M | $77.26M | $82.38M | $79.36M | $80.63M | $79.42M | $79.22M | $75.59M | $74.19M | $67.40M | $58.64M | $53.37M | $41.80M | $38.38M | $35.82M | $33.81M |
| Avg Forecast | $95.75M | $94.00M | $92.71M | $89.50M | $89.77M | $87.79M | $86.86M | $82.57M | $81.53M | $79.53M | $67.85M | $63.13M | $63.66M | $53.14M | $61.77M | $80.70M | $81.67M | $82.62M | $81.85M | $78.92M | $77.00M | $74.11M | $67.76M | $61.05M | $55.51M | $51.90M | $35.61M | $38.02M | $35.78M | $33.14M |
| High Forecast | $97.07M | $95.28M | $93.98M | $90.73M | $91.00M | $89.00M | $88.05M | $83.70M | $82.65M | $81.05M | $68.78M | $63.99M | $64.53M | $53.87M | $62.61M | $81.80M | $82.79M | $83.76M | $83.18M | $80.20M | $78.25M | $75.31M | $68.86M | $62.04M | $56.41M | $52.74M | $36.18M | $38.63M | $36.36M | $33.68M |
| Low Forecast | $92.59M | $90.89M | $89.64M | $86.55M | $86.80M | $84.89M | $83.99M | $79.84M | $78.83M | $77.49M | $65.61M | $61.04M | $61.55M | $51.38M | $59.72M | $78.03M | $78.97M | $79.89M | $79.44M | $76.59M | $74.72M | $71.92M | $65.76M | $59.24M | $53.87M | $50.36M | $34.55M | $36.89M | $34.72M | $32.17M |
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 9 | 5 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.26% | 1.14% | 0.96% | 1.01% | 0.96% | 0.99% | 1.01% | 1.03% | 1.02% | 1.09% | 1.10% | 1.06% | 1.03% | 1.17% | 1.01% | 1.00% | 1.02% |
CareDx's average Quarter revenue forecast for Dec 23 based on 4 analysts is $63.66M, with a low forecast of $61.55M, and a high forecast of $64.53M. CDNA's average Quarter revenue forecast represents a -5.26% decrease compared to the company's last Quarter revenue of $67.19M (Sep 23).
CareDx EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 9 | 5 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-28.78M | $-27.62M | $-24.33M | $-19.14M | $-13.03M | $-18.12M | $-15.55M | $-13.65M | $-9.04M | $814.00K | $1.68M | $-1.09M | $-610.00K | $-4.61M | $-3.89M | $-3.30M | $-1.30M |
| Avg Forecast | $-17.50M | $-17.18M | $-16.94M | $-16.36M | $-16.41M | $-16.04M | $-15.87M | $-15.09M | $-14.90M | $-14.53M | $-12.40M | $15.83M | $-11.63M | $-9.71M | $-11.29M | $16.93M | $-14.92M | $-44.74M | $-14.72M | $-14.42M | $-14.07M | $-13.54M | $-12.38M | $18.11M | $-10.14M | $-9.48M | $-6.51M | $-23.35M | $-6.54M | $-6.06M |
| High Forecast | $-16.92M | $-16.61M | $-16.38M | $-15.82M | $-15.86M | $-15.51M | $-15.35M | $-14.59M | $-14.41M | $-14.16M | $-11.99M | $19.00M | $-11.25M | $-9.39M | $-10.91M | $20.32M | $-14.43M | $-35.79M | $-11.78M | $-14.00M | $-13.66M | $-13.14M | $-12.02M | $21.73M | $-9.85M | $-9.20M | $-6.31M | $-18.68M | $-6.35M | $-5.88M |
| Low Forecast | $-17.74M | $-17.41M | $-17.17M | $-16.58M | $-16.63M | $-16.26M | $-16.09M | $-15.30M | $-15.10M | $-14.81M | $-12.57M | $12.67M | $-11.79M | $-9.84M | $-11.44M | $13.55M | $-15.13M | $-53.69M | $-17.67M | $-14.66M | $-14.30M | $-13.76M | $-12.58M | $14.49M | $-10.31M | $-9.64M | $-6.61M | $-28.02M | $-6.64M | $-6.16M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.96% | 2.45% | -1.44% | 1.28% | 0.29% | 1.23% | 1.08% | 0.97% | 0.67% | -0.07% | 0.09% | 0.11% | 0.06% | 0.71% | 0.17% | 0.50% | 0.21% |
2 analysts predict CDNA's average Quarter EBITDA for Sep 21 to be $-13.54M, with a high of $-13.14M and a low of $-13.76M. This is -1763.84% lower than CareDx's previous annual EBITDA (Jun 21) of $814.00K.
CareDx Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 9 | 5 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-23.48M | $-24.95M | $-23.75M | $-18.33M | $-16.94M | $-21.70M | $-19.65M | $-16.15M | $-11.90M | $-1.93M | $-687.00K | $-3.52M | $-2.82M | $-6.56M | $-5.82M | $-4.78M | $-1.81M |
| Avg Forecast | $-1.50M | $-2.95M | $-3.72M | $-6.06M | $-7.62M | $-9.35M | $-9.82M | $-12.71M | $-12.11M | $-13.37M | $-20.82M | $-6.49M | $-23.31M | $-30.71M | $-28.43M | $-6.94M | $-17.42M | $-58.89M | $-17.75M | $-14.35M | $-7.20M | $-7.18M | $-4.49M | $-7.42M | $-7.19M | $-10.23M | $-7.83M | $-34.94M | $-8.09M | $-7.96M |
| High Forecast | $-1.43M | $-2.82M | $-3.56M | $-5.80M | $-7.29M | $-8.95M | $-9.40M | $-12.16M | $-11.59M | $-12.79M | $-19.93M | $-5.19M | $-22.31M | $-29.39M | $-27.20M | $-5.55M | $-16.67M | $-47.11M | $-14.20M | $-13.80M | $-6.93M | $-6.90M | $-4.32M | $-5.94M | $-6.92M | $-9.84M | $-7.53M | $-27.95M | $-7.78M | $-7.65M |
| Low Forecast | $-1.52M | $-3.00M | $-3.79M | $-6.17M | $-7.75M | $-9.51M | $-10.00M | $-12.94M | $-12.32M | $-13.60M | $-21.19M | $-7.78M | $-23.73M | $-31.26M | $-28.93M | $-8.32M | $-17.73M | $-70.67M | $-21.30M | $-14.66M | $-7.35M | $-7.33M | $-4.58M | $-8.90M | $-7.35M | $-10.45M | $-7.99M | $-41.93M | $-8.26M | $-8.13M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.76% | 0.88% | 3.42% | 1.05% | 0.29% | 1.22% | 1.37% | 2.24% | 1.66% | 0.43% | 0.09% | 0.49% | 0.28% | 0.84% | 0.17% | 0.59% | 0.23% |
CareDx's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. CDNA's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
CareDx SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 9 | 5 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $52.44M | $50.96M | $51.26M | $48.44M | $46.09M | $52.18M | $49.71M | $45.57M | $40.04M | $35.92M | $30.68M | $29.50M | $26.99M | $24.45M | $21.73M | $19.70M | $20.54M |
| Avg Forecast | $56.51M | $55.47M | $54.71M | $52.82M | $52.98M | $51.81M | $51.26M | $48.72M | $48.11M | $46.93M | $40.04M | $37.25M | $37.57M | $31.36M | $36.45M | $47.62M | $48.19M | $48.76M | $42.69M | $46.57M | $45.44M | $43.73M | $39.99M | $36.02M | $32.76M | $30.63M | $21.01M | $22.43M | $21.12M | $19.56M |
| High Forecast | $57.28M | $56.23M | $55.46M | $53.54M | $53.70M | $52.52M | $51.96M | $49.39M | $48.77M | $47.83M | $40.59M | $37.76M | $38.08M | $31.79M | $36.95M | $48.27M | $48.85M | $49.43M | $51.23M | $47.33M | $46.17M | $44.44M | $40.63M | $36.61M | $33.29M | $31.12M | $21.35M | $22.80M | $21.46M | $19.88M |
| Low Forecast | $54.64M | $53.63M | $52.90M | $51.07M | $51.22M | $50.09M | $49.56M | $47.11M | $46.52M | $45.73M | $38.72M | $36.02M | $36.32M | $30.32M | $35.24M | $46.05M | $46.60M | $47.14M | $34.16M | $45.20M | $44.10M | $42.44M | $38.80M | $34.96M | $31.79M | $29.72M | $20.39M | $21.77M | $20.49M | $18.98M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.67% | 1.40% | 1.08% | 1.01% | 0.95% | 1.22% | 1.07% | 1.00% | 0.92% | 0.90% | 0.85% | 0.90% | 0.88% | 1.16% | 0.97% | 0.93% | 1.05% |
CareDx's average Quarter SG&A projection for Dec 23 is $37.57M, based on 4 Wall Street analysts, with a range of $36.32M to $38.08M. The forecast indicates a -28.37% fall compared to CDNA last annual SG&A of $52.44M (Sep 23).
CareDx EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 9 | 5 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.43 | $-0.00 | $-0.44 | $-0.34 | $-0.32 | $-0.41 | $-0.37 | $-0.31 | $-0.23 | $-0.04 | $-0.01 | $-0.07 | $-0.06 | $-0.15 | $-0.14 | $-0.11 | $-0.04 |
| Avg Forecast | $-0.03 | $-0.06 | $-0.07 | $-0.12 | $-0.15 | $-0.18 | $-0.19 | $-0.24 | $-0.23 | $-0.26 | $-0.40 | $-0.47 | $-0.45 | $-0.59 | $-0.54 | $-0.32 | $-0.33 | $-0.39 | $-0.34 | $-0.28 | $-0.14 | $-0.14 | $-0.09 | $-0.12 | $-0.14 | $-0.20 | $-0.15 | $-0.13 | $-0.15 | $-0.15 |
| High Forecast | $-0.03 | $-0.05 | $-0.07 | $-0.11 | $-0.14 | $-0.17 | $-0.18 | $-0.23 | $-0.22 | $-0.25 | $-0.38 | $-0.45 | $-0.43 | $-0.56 | $-0.52 | $-0.31 | $-0.32 | $-0.38 | $-0.33 | $-0.26 | $-0.13 | $-0.13 | $-0.08 | $-0.11 | $-0.13 | $-0.19 | $-0.14 | $-0.13 | $-0.15 | $-0.15 |
| Low Forecast | $-0.03 | $-0.06 | $-0.07 | $-0.12 | $-0.15 | $-0.18 | $-0.19 | $-0.25 | $-0.24 | $-0.26 | $-0.41 | $-0.48 | $-0.45 | $-0.60 | $-0.55 | $-0.33 | $-0.34 | $-0.40 | $-0.35 | $-0.28 | $-0.14 | $-0.14 | $-0.09 | $-0.12 | $-0.14 | $-0.20 | $-0.15 | $-0.14 | $-0.16 | $-0.16 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.73% | 0.00% | 1.36% | 1.02% | 0.82% | 1.21% | 1.35% | 2.25% | 1.67% | 0.47% | 0.08% | 0.51% | 0.31% | 1.00% | 1.06% | 0.71% | 0.26% |
According to undefined Wall Street analysts, CareDx's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CDNA previous annual EPS of $NaN (undefined).
CareDx Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| DRIO | DarioHealth | $0.87 | $10.75 | 1135.63% | Buy |
| GTH | Genetron | $4.03 | $10.00 | 148.14% | - |
| GH | Guardant Health | $25.09 | $57.27 | 128.26% | Buy |
| BDSX | Biodesix | $1.80 | $3.00 | 66.67% | Buy |
| ILMN | Illumina | $130.21 | $200.82 | 54.23% | Buy |
| CRL | Charles River Laboratories | $206.21 | $316.29 | 53.38% | Buy |
| EXAS | Exact Sciences | $67.99 | $94.33 | 38.74% | Buy |
| PSNL | Personalis | $5.67 | $7.75 | 36.68% | Hold |
| CSTL | Castle Biosciences | $31.25 | $38.00 | 21.60% | Buy |
| CDNA | CareDx | $30.12 | $31.00 | 2.92% | Buy |
| MYGN | Myriad Genetics | $28.60 | $27.67 | -3.25% | Hold |
| NTRA | Natera | $127.21 | $114.38 | -10.09% | Buy |
| TWST | Twist Bioscience | $47.67 | $42.40 | -11.06% | Buy |
CDNA Forecast FAQ
Is CareDx a good buy?
Yes, according to 6 Wall Street analysts, CareDx (CDNA) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 66.67% of CDNA's total ratings.
What is CDNA's price target?
CareDx (CDNA) average price target is $31 with a range of $15 to $40, implying a 2.92% from its last price of $30.12. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will CareDx stock go up soon?
According to Wall Street analysts' prediction for CDNA stock, the company can go up by 2.92% (from the last price of $30.12 to the average price target of $31), up by 32.80% based on the highest stock price target, and down by -50.20% based on the lowest stock price target.
Can CareDx stock reach $50?
CDNA's average twelve months analyst stock price target of $31 does not support the claim that CareDx can reach $50 in the near future.
What is CareDx's current price target trend?
1 Wall Street analyst forecast a $40 price target for CareDx (CDNA) this month, up 32.80% from its last price of $30.12. Compared to the last 3 and 12 months, the average price target increased by 23.94% and increased by 5.41%, respectively.
What are CareDx's analysts' financial forecasts?
CareDx's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $346.99M (high $351.74M, low $335.51M), average EBITDA is $-63.411M (high $-61.314M, low $-64.28M), average net income is $-39.496M (high $-37.798M, low $-40.199M), average SG&A $204.76M (high $207.57M, low $197.99M), and average EPS is $-0.757 (high $-0.724, low $-0.77). CDNA's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $371.97M (high $377.06M, low $359.66M), average EBITDA is $-67.976M (high $-65.728M, low $-68.908M), average net income is $-14.223M (high $-13.612M, low $-14.477M), average SG&A $219.5M (high $222.51M, low $212.25M), and average EPS is $-0.272 (high $-0.261, low $-0.277).
Did the CDNA's actual financial results beat the analysts' financial forecasts?
Based on CareDx's last annual report (Dec 2022), the company's revenue was $321.79M, which missed the average analysts forecast of $325.07M by -1.01%. Apple's EBITDA was $-77.338M, missing the average prediction of $-88.816M by -12.92%. The company's net income was $-76.613M, missing the average estimation of $-108M by -29.34%. Apple's SG&A was $196.42M, beating the average forecast of $186.22M by 5.48%. Lastly, the company's EPS was $-1.44, beating the average prediction of $-1.341 by 7.40%. In terms of the last quarterly report (Sep 2023), CareDx's revenue was $67.19M, beating the average analysts' forecast of $53.14M by 26.44%. The company's EBITDA was $-28.783M, beating the average prediction of $-9.711M by 196.38%. CareDx's net income was $-23.485M, missing the average estimation of $-30.708M by -23.52%. The company's SG&A was $52.44M, beating the average forecast of $31.36M by 67.23%. Lastly, the company's EPS was $-0.43, missing the average prediction of $-0.588 by -26.91%